Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial

Diabetes Care - United States
doi 10.2337/dc15-2763
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations From the SAVOR-TIMI 53 Randomized TrialCLINICAL PERSPECTIVE

Circulation
Cardiovascular MedicinePhysiologyCardiology
2014English

Health-Related Quality-Of-Life Implications of Cardiovascular Events in Individuals With Type 2 Diabetes Mellitus: A Subanalysis From the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients With Diabetes Mellitus (SAVOR)-TIMI 53 Trial

Diabetes Research and Clinical Practice
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2017English

Adverse Events in Patients Taking Cephalosporins Versus Placebo for Any Indication

Cochrane Database of Systematic Reviews
2020English

Cerebral Blood Perfusion Predicts Response to Sertraline Versus Placebo for Major Depressive Disorder in the EMBARC Trial

EClinicalMedicine
Medicine
2019English

Adverse Events in People Taking Macrolide Antibiotics Versus Placebo for Any Indication

Cochrane Database of Systematic Reviews
2019English

PL02.01 Overall Survival With Durvalumab Versus Placebo After Chemoradiotherapy in Stage III NSCLC: Updated Results From PACIFIC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Efficacy and Safety of Duloxetine Versus Placebo in Adolescents With Juvenile Fibromyalgia: Results From a Randomized Controlled Trial

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2019English

Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents With Major Depressive Disorder

Journal of Child and Adolescent Psychopharmacology
Mental HealthChild HealthPharmacologyPerinatologyPsychiatryPediatrics
2018English

Risk Factors for Major Bleeding in the SEATTLE II Trial

Vascular Medicine
MedicineCardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy